Wikipedia -WSS

Wikipedia

author：hotspot 2025-09-29 22:46:59 - browse：93

Adam's take main illustration — Molly Ferguson/STAT

The eye disease physician in charge of a committee that flagged a rare but severe side effect involving a newly approved drug from Apellis Pharmaceuticals has financial ties to a competing drugmaker. The conflict raises questions about his supervision of an emerging safety issue for patients and its impact on the financial health of Apellis.

Peter Kaiser, a retinal disease expert who runs the Cole Eye Institute at the Cleveland Clinic, failed to report consulting fees and stock ownership in Iveric Bio on a financial disclosure form maintained by the American Society of Retina Specialists, or ASRS. Iveric Bio is developing a treatment for geographic atrophy, a common, age-related cause of vision loss and the same indication for which the Apellis drug was approved.

The financial conflict, which was undisclosed until after Kaiser was contacted about it by STAT, is relevant because Kaiser also chairs a committee of the ASRS responsible for monitoring the safety of retina drugs and devices. On July 15, Kaiser’s committee sent a letter to member doctors, alerting them to reports of eye inflammation in people receiving injections of Syfovre, the treatment recently approved and launched by Apellis.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Eliminate the waiting period for sterilization covered by Medicaid

explore

WSS

Patient advocates debate FDA's accelerated approval process

Sage considers ways to reduce costs following FDA rejection

Judge in Trump's classified documents case questions use of out

Judge in Trump's classified documents case questions use of out

Sage considers ways to reduce costs following FDA rejection

Doctors push to include dialysis machines in emergency stockpile

hotspot

Wikipedia

leisure time

Peter Hotez and the public health issue of online harassment

Trump used to be more articulate. What could explain the change?

Continuity nursing helped my family in our darkest PICU moments

Decaf coffee targeted by food safety group under obscure FDA rule

Continuity nursing helped my family in our darkest PICU moments

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Medical leaders decry Supreme Court decision on affirmative action

Primary care physicians play key roles in Alzheimer's management

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: mifepristone case, GLP

Wikipedia

Tuberculosis patients need more than just free medication

Many breast cancer patients receive more radiation than needed

Flash flood warnings continue for parts of Missouri, Illinois

'Brian's Song' at 50 still offers lessons about cancer for today

Readout Newsletter: Merck, Vertex, and Viking updates

Merck drug for rare lung condition set for approval in U.S.

leisure time

focus

explore

focus